LIVN: Volatility Compression detected on 26 Jun 2026

LIVN shows a volatility compression pattern driven by improving fundamentals and strong technical uptrend signals reinforced by a positive earnings call with raised 2026 guidance. The stock trades at $81.05, compressed between key support at $69.58 and resistance at $82.66, with RSI at 69.47 indicating near-overbought conditions. Structure score of 15/15 reflects excellent pattern organization, though breakout confidence is moderate at 10/13. Volume confirms the pattern with a 0.84 ratio. The 61.73% win probability and 72 overall score signal a viable setup near its 52-week high, up 97.61% from lows.

LivaNova will announce second-quarter 2026 results on August 5, 2026. Recent catalysts include FDA premarket approval for the aura6000 System for moderate to severe obstructive sleep apnea with launch expected in H1 2027, and demonstration of 84.5% cumulative response rate with PolySync programming in the OSPREY study for obstructive sleep apnea. On June 10, 2026, LivaNova shareholders approved all 10 AGM proposals, including share buyback authorization up to 10 percent, reinforcing capital management flexibility. Valuation remains elevated at P/E ~39 alongside ongoing cash flow variability and execution risks including supply constraints and reimbursement uncertainty.

A successful breakout above resistance at $82.66 would target a conservative measured move of $83.32, representing 2.9% upside from current price. The pattern would gain credibility on elevated volume confirming the escape from compression—historical data shows the 61.73% win probability favors breakout attempts in volatility compression structures. The invalidation level sits at key support of $69.58, a 12.5% drawdown from current levels; closure below this support negates the setup and signals pattern failure. Higher beta at 0.59 provides relative stability during breakout execution.

RSI at 69.47 flags near-overbought conditions that could invite profit-taking. Most recent analyst rating is a Hold with a $76.00 price target—notably below current price, suggesting limited upside in consensus expectations. Q2 earnings call on August 5 arrives in 40 days and represents binary catalyst risk. Volume fell 688k shares on last session despite price gains, creating a price-volume divergence warning of potential reversal. Supply constraints, reimbursement uncertainty, and cash flow variability present operational headwinds. Current volume at 652k is 16% below 20-day average, raising concerns about breakout sustainability.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.